Adam J. Townsend, Chief Commercial Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 695 shares at $29.52 ($21K) on 2025-01-29, disclosed to the SEC on 2025-01-30.
Seasonal sale ($21k) by Chief Commercial Officer — this insider has traded APLS in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| APLS | SELL | 2025-01-14 | $154K | — | Filing → |
| APLS | SELL | 2024-02-13 | $156K | — | Filing → |
| APLS | SELL | 2024-01-31 | $116K | — | Filing → |